Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic
Introduction: Psychotropic drug-drug interactions (DDIs) contribute to adverse drug events, but many go undetected or unmanaged. Thorough documentation of potential DDIs can improve patient safety. The primary objective of this study is to determine the quality of and factors associated with documen...
Saved in:
Main Authors: | Kathryn Collins, PharmD, MSPH (Author), Julie A. Dopheide, PharmD, BCPP, FASHP (Author), Mengxi Wang, MPH (Author), Talene Keshishian, MD (Author) |
---|---|
Format: | Book |
Published: |
American Association of Psychiatric Pharmacists,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022) -
Terbinafine and risperidone drug interaction contributing to clinical changes in a forensic psychiatric patient
by: Reynolds Jamie PharmD, et al.
Published: (2023) -
A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
by: Jonathan F. Lister, PharmD, BCPP, et al.
Published: (2022) -
Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023) -
Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
by: Richard J. Silvia, PharmD, BCPP, et al.
Published: (2022)